CEO Gary Guthart quelled concerns of reflexive pricing, with production and manufacturing optimisation a priority instead.

Barclays lowered the firm’s price target on Intuitive Surgical (ISRG) to $635 from $684 and keeps an Overweight rating on the shares following ...

Intuitive Surgical is the world’s leading robotic surgery company, and it has a solid earnings track record. The company ...

Intuitive Surgical's price target was cut to $590 on tariff concerns, but analysts remain positive on strong growth, new ...

Intuitive Surgical stock reversed bullishly Wednesday after investors digested the robotic surgery titan's conservative ...

Surgical is warning that President Donald Trump's import taxes and retaliation from trade partners could have a significant ...

CFO Jamie Samath cautioned that the trade environment, financial pressures on hospitals and macroeconomic risks could extend ...

RBC Capital lowered the firm’s price target on Intuitive Surgical (ISRG) to $605 from $630 and keeps an Outperform rating on the shares. The ...

Intuitive (the "Company") (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today ...

Bruker Corporation today announced the launch of the nVista 2P miniature, two-photon microscope, a groundbreaking addition to ...

Well, a leading innovator in AI-driven health engagement, has secured $30 million in additional funding. This investment propels Well's total funding to over $150 million, to help fuel the expansion ...

Designed for ease of use and efficiency, our guide highlights the benefits of small oncology panels, including faster ...